| pubmed-article:21402291 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C0087130 | lld:lifeskim |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C0679006 | lld:lifeskim |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C1533716 | lld:lifeskim |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C1518681 | lld:lifeskim |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C0150312 | lld:lifeskim |
| pubmed-article:21402291 | lifeskim:mentions | umls-concept:C1517001 | lld:lifeskim |
| pubmed-article:21402291 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:21402291 | pubmed:dateCreated | 2011-3-15 | lld:pubmed |
| pubmed-article:21402291 | pubmed:abstractText | Standard approaches to estimation of Markov models with data from randomized controlled trials tend either to make a judgment about which transition(s) treatments act on, or they assume that treatment has a separate effect on every transition. An alternative is to fit a series of models that assume that treatment acts on specific transitions. Investigators can then choose among alternative models using goodness-of-fit statistics. However, structural uncertainty about any chosen parameterization will remain and this may have implications for the resulting decision and the need for further research. | lld:pubmed |
| pubmed-article:21402291 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21402291 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21402291 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21402291 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21402291 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21402291 | pubmed:issn | 1524-4733 | lld:pubmed |
| pubmed-article:21402291 | pubmed:author | pubmed-author:AdesA EAE | lld:pubmed |
| pubmed-article:21402291 | pubmed:author | pubmed-author:BriggsAndrew... | lld:pubmed |
| pubmed-article:21402291 | pubmed:author | pubmed-author:WeltonNicky... | lld:pubmed |
| pubmed-article:21402291 | pubmed:author | pubmed-author:PriceMalcolm... | lld:pubmed |
| pubmed-article:21402291 | pubmed:copyrightInfo | Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:21402291 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21402291 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:21402291 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21402291 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21402291 | pubmed:pagination | 205-18 | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:meshHeading | pubmed-meshheading:21402291... | lld:pubmed |
| pubmed-article:21402291 | pubmed:articleTitle | Model averaging in the presence of structural uncertainty about treatment effects: influence on treatment decision and expected value of information. | lld:pubmed |
| pubmed-article:21402291 | pubmed:affiliation | School of Social and Community-Based Medicine, University of Bristol, Bristol, UK. Malcolm.price@bristol.ac.uk | lld:pubmed |
| pubmed-article:21402291 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21402291 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
